Announced an on-market share buy-back program for up to 10% of the Company’s issued capital • Under the Corporations Act, Mayne Pharma may buy back up to 10% of issued capital in any 12-month period without shareholder approval • The buy-back will be funded from Mayne Pharma’s current cash reserves • Mayne Pharma’s Board intends to maintain a conservative balance sheet following completion of the buy-back and will continue to assess the merits of this capital management plan as market conditions evolve
- Forums
- ASX - By Stock
- MYX
- Sale of retail generics portfolio
MYX
mayne pharma group limited
Add to My Watchlist
0.00%
!
$5.05

Sale of retail generics portfolio, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.05 |
Change
0.000(0.00%) |
Mkt cap ! $412.7M |
Open | High | Low | Value | Volume |
$5.00 | $5.08 | $4.80 | $1.775M | 357.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 5646 | $5.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.06 | 1360 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 5460 | 5.030 |
2 | 207 | 5.020 |
5 | 1335 | 5.010 |
5 | 2580 | 5.000 |
3 | 941 | 4.990 |
Price($) | Vol. | No. |
---|---|---|
5.060 | 1503 | 11 |
5.070 | 964 | 5 |
5.080 | 1150 | 4 |
5.090 | 6190 | 5 |
5.100 | 20670 | 3 |
Last trade - 13.23pm 21/07/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |